Showing results (421-430 of 1,004) with videos related to
Sort By:
Pageof 101
Anti-Cancer Drug Design|May 17, 2001
Antineoplastic agents 442. Synthesis and biological activities of dioxostatinG R Pettit, J W Lippert, M R Boyd, et al.Journal of Medicinal Chemistry|February 1, 1979
Easily hydrolyzable, water-soluble derivatives of (+/-)-alpha-5-[1-(indol-3-yl)ethyl]-2-methylamino-delta2-thiazoline-4-one, a novel antiviral compoundM R Harnden, S Bailey, M R Boyd, et al.Neuroscience|September 1, 1995
Cytochrome P450 and associated monooxygenase activities in the rat and human spinal cord: induction, immunological characterization and immunocytochemical localizationS V Bhagwat, B C Leelavathi, S K Shankar, et al.Toxicology and Applied Pharmacology|January 1, 1984
Acute inhalation toxicity of 3-methylfuran in the mouse: pathology, cell kinetics, and respiratory rate effectsW M Haschek, M R Boyd, P J Hakkinen, et al.Journal of Natural Products|November 1, 1996
Cytotoxic triterpenes from a marine sponge, Stelletta spJ L McCormick, T C McKee, J H Cardellina, et al.Archives of Biochemistry and Biophysics|March 9, 2002
Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbitalSudarshan C Upadhya, Shankar J Chinta, Harish V Pai, et al.Journal of Surgical Oncology|January 1, 1976
Plasma CEA, tumor CEA, and tumor histologyC R Boyd, B A Bivens, R Kashmiri, et al.Implementation Research and Practice|April 24, 2023
Tailored isn't always better: Impact of standardized versus tailored training on intention to use measurement-based careHannah Kassab, Kelli Scott, Meredith R Boyd, et al.Epigenomes|December 10, 2019
Disruption of Broad Epigenetic Domains in PDAC Cells by HAT InhibitorsDiana L Gerrard, Joseph R Boyd, Gary S Stein, et al.Epidemiology and Infection|September 15, 2015
High burden of invasive group A streptococcal disease in the Northern Territory of AustraliaR Boyd, M Patel, B J Currie, et al.Pageof 101